It has been shown that although glucagon has these effects, the glucose response to glucagon in individuals with insulin-treated diabetes is highly variable, influenced by the levels of insulin and the ratio of insulin to glucagon in the body, along with the timing of the most recent injection. The gene discussed is INS; the disease is diabetes mellitus.